查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1768951

外泌体研究产品的全球市场

Exosome Research Products
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 178 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年，外泌体研究产品的全球市场将达到 13 亿美元

2024年，全球外泌体研究产品市场规模估计为4.123亿美元，预计到2030年将达到13亿美元，在2024-2030年的分析期内，复合年增长率为20.6%。套件和试剂是本报告分析的细分市场之一，预计其复合年增长率为22.2%，到分析期结束时市场规模将达到6.978亿美元。设备细分市场在分析期间内的复合年增长率估计为20.0%。

美国市场规模估计为 1.202 亿美元，中国市场预计复合年增长率为 19.8%

美国外泌体研究产品市场规模预估2024年达到1.202亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到1.933亿美元，在2024-2030年的分析期间内，复合年增长率为19.8%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为18.3%和16.9%。在欧洲，预计德国市场的复合年增长率约为13.7%。

全球外泌体研究产品市场－主要趋势与驱动因素摘要

什么是外泌体研究产品？为什么它们很重要？

外泌体研究产品，包括分离试剂套件、精製试剂和表征工具，对于外泌体的研究至关重要。外泌体是一种在细胞间通讯中发挥关键作用并与多种生物过程相关的小型细胞外囊泡。外泌体含有来自母细胞的蛋白质、RNA、DNA 和脂质，是许多疾病的宝贵生物标记物，包括癌症、神经退化性疾病和心血管疾病。由于外泌体能够携带复杂的生物讯息，因此被广泛用于诊断、治疗和药物传递应用的研究。例如，在肿瘤学中，外泌体为了解肿瘤行为提供了宝贵的见解，并提供了一种监测疾病进展和治疗反应的非侵入性方法。由于其作为生物标记的潜力，外泌体研究产品在需要可靠的外泌体分离、精製和分析工具的研究人员中需求量很大。

外泌体研究在再生医学和免疫疗法中也发挥重要作用，因为外泌体可以作为治疗载体，将药物或遗传物质递送至目标细胞。基于外泌体的药物递送系统因其能够实现标靶治疗且副作用极小而备受关注，尤其是在个人化医疗领域。随着外泌体应用的不断扩展，高品质、可靠的研究产品对于推进药物开发和诊断领域的探索至关重要。学术机构、生技公司和製药公司不断增加的资金支持外泌体研究的兴趣日益浓厚，使得外泌体研究成为医学领域中一个快速发展的领域。

科技进步如何促进外泌体研究？

技术进步极大地改变了外泌体的研究，使得这些囊泡的分离、表征和分析更有效率和准确。外泌体研究的关键挑战之一是准确且可重复地分离外泌体，因为它们体积小且通常以低浓度存在于体液中。超速离心、亲和性和捕获和微流体分离技术的最新创新简化了该流程，使研究人员能够获得高纯度的外泌体样本。这些进步不仅提高了研究质量，而且还为分子分析和治疗开发等下游应用提供了更可靠的数据。此外，次世代定序(NGS) 和蛋白质组学的发展提高了解剖外泌体内容物的能力，使研究人员能够识别用于早期检测疾病的特定生物标记。

此外，结合人工智慧 (AI) 和机器学习 (ML) 的高通量筛检技术正在实现对大型外泌体资料集的快速分析。这些工具将有助于发现新的生物标记和开发基于外泌体的诊断测试，从而加速精准医疗的进步。流式细胞技术、奈米粒子追踪分析 (NTA) 和电子显微镜的进步也显着改善了外泌体的表征，使研究人员能够以前所未有的精度分析颗粒大小、浓度和分子组成。这些技术突破的结合正在扩展外泌体研究产品的功能，使科学家能够充分发挥外泌体在诊断、治疗和药物传输方面的潜力。

外泌体研究的新应用为何不断出现？

外泌体的多功能性使其应用领域从诊断扩展到药物递送，甚至疫苗开发。在诊断领域，外泌体已被证明是多种疾病（包括癌症、神经退化性疾病和心血管疾病）的宝贵非侵入性生物标记。由于外泌体可以从血液和尿液等易于获取的体液中获取，它们代表了传统切片检查的一种有希望的替代方案，可以即时监测病情进展和治疗反应。液态切片的这些潜在应用促使製药公司和研究机构投资外泌体研究产品，希望开发出能够改善疾病早期检测的高效、非侵入性诊断测试。

製药业也在探索将外泌体用作药物递送载体，因为它们具有天然的生物相容性，并且能够穿过血脑障壁等生物屏障。这项特性使外泌体特别适用于在治疗神经系统疾病时将药物送到大脑等难以到达的部位。此外，基于外泌体的治疗方法在再生医学中也备受关注，它们透过向目标细胞递送生长因子来促进组织修復和创伤治疗。疫苗开发也是一个新兴领域，其中外泌体正在被测试作为抗原载体在调节免疫反应中的作用。外泌体在多个医学领域的不断扩展应用推动了对外泌体专用研究产品的需求，这些产品支持外泌体的分离、修饰和功能分析，以用于治疗和诊断目的。

是什么推动了全球外泌体研究产品市场的成长？

外泌体研究产品市场的成长受到多种因素的驱动，这些因素源于技术创新、外泌体应用范围的不断扩大以及对生物医学研究的投资不断增加。外泌体分离和表征工具的技术进步显着提高了外泌体研究的准确性和效率，使其能够用于生物标记发现和治疗递送等敏感应用。随着外泌体的诊断和治疗用途不断扩大，製药和生物技术公司正在大力投资开发基于外泌体的产品，特别是用于癌症诊断、神经退化性疾病和再生疗法。这些因素推动了对外泌体分离、分析和改造的高品质研究产品的需求。此外，个人化医疗的兴起和对非侵入性诊断工具的需求是市场成长的主要驱动力，因为外泌体为疾病监测和药物递送提供了一种微创选择。公共和私营部门的资金投入不断增加也加速了市场的发展，因为医疗机构意识到外泌体研究在解决尚未满足的医疗需求方面的潜力。人们对开发基于外泌体的疗法以及利用外泌体进行疫苗递送的兴趣日益浓厚，进一步推动了对专用研究产品的需求。综合起来，这些因素使外泌体研究成为生命科学的关键领域，并支持外泌体分离套件、表征工具和分析技术市场的持续成长。

部分

组件（套件/试剂、设备、服务）、应用（肺癌、乳癌、前列腺癌、结肠癌、其他应用）、最终用途（学术/研究机构、製药/生物技术公司、医院/临床实验室）

受访公司范例

  • AMS Biotechnology Ltd.
  • Bio-Techne
  • Lonza Group AG
  • Miltenyi Biotech
  • Nanosomix
  • Norgen Biotek Corp.
  • NX Pharmagen
  • Qiagen NV
  • System Biosciences（SBI）
  • Thermo Fisher Scientific Inc.

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP21745

Global Exosome Research Products Market to Reach US$1.3 Billion by 2030

The global market for Exosome Research Products estimated at US$412.3 Million in the year 2024, is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 20.6% over the analysis period 2024-2030. Kits & Reagents, one of the segments analyzed in the report, is expected to record a 22.2% CAGR and reach US$697.8 Million by the end of the analysis period. Growth in the Instruments segment is estimated at 20.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$120.2 Million While China is Forecast to Grow at 19.8% CAGR

The Exosome Research Products market in the U.S. is estimated at US$120.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$193.3 Million by the year 2030 trailing a CAGR of 19.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 18.3% and 16.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.7% CAGR.

Global Exosome Research Products Market - Key Trends & Drivers Summarized

What Are Exosome Research Products and Why Are They Important?

Exosome research products, including isolation kits, purification reagents, and characterization tools, are essential in studying exosomes-small extracellular vesicles that play a critical role in cell-to-cell communication and are linked to a variety of biological processes. Exosomes contain proteins, RNA, DNA, and lipids from their parent cells, making them valuable biomarkers for numerous diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases. With their ability to carry complex biological information, exosomes are used extensively in research for diagnostics, therapeutics, and drug delivery applications. For instance, in oncology, exosomes provide valuable insights into tumor behavior and offer a non-invasive approach to monitoring disease progression and response to treatments. Their potential as biomarkers has led to an increasing demand for exosome research products, as researchers seek reliable tools for exosome isolation, purification, and analysis.

Exosome research is also critical in regenerative medicine and immunotherapy, as exosomes can serve as carriers for therapeutic agents, delivering drugs or genetic material to targeted cells. The use of exosome-based drug delivery systems is gaining traction, especially in personalized medicine, where they enable targeted treatment with minimal side effects. As exosome applications expand, high-quality, reliable research products are crucial for advancing discoveries in drug development and diagnostics. The growing interest in exosome research is supported by increased funding from academic institutions, biotechnology firms, and pharmaceutical companies, making exosome research products a rapidly evolving field in medical science.

How Are Technological Advancements Enhancing Exosome Research?

Technological advancements have significantly transformed exosome research, making the isolation, characterization, and analysis of these vesicles more efficient and precise. One of the critical challenges in exosome research is the accurate and reproducible isolation of exosomes, as they are small and often found in low concentrations in biological fluids. Recent innovations in isolation techniques, such as ultracentrifugation, immunoaffinity capture, and microfluidics, have streamlined the process, enabling researchers to obtain high-purity exosome samples. These advancements not only improve the quality of research but also allow for more reliable data in downstream applications like molecular profiling and therapeutic development. Additionally, developments in next-generation sequencing (NGS) and proteomics have enhanced the ability to analyze exosomal content in detail, enabling researchers to identify specific biomarkers for early disease detection.

Furthermore, high-throughput screening technologies, combined with artificial intelligence (AI) and machine learning (ML), are enabling rapid analysis of large exosome datasets. These tools facilitate the discovery of novel biomarkers and the development of exosome-based diagnostic tests, accelerating progress in precision medicine. Advancements in flow cytometry, nanoparticle tracking analysis (NTA), and electron microscopy have also significantly improved exosome characterization, allowing researchers to analyze particle size, concentration, and molecular composition with unprecedented accuracy. Together, these technological breakthroughs are expanding the capabilities of exosome research products, allowing scientists to unlock the full potential of exosomes in diagnostics, therapeutics, and drug delivery.

Why Are New Applications for Exosome Research Emerging?

The versatility of exosomes is driving their adoption in an increasing number of applications, from diagnostics to drug delivery and even vaccine development. In diagnostics, exosomes are proving to be valuable non-invasive biomarkers for a variety of conditions, including cancer, neurodegenerative diseases, and cardiovascular disorders. Since exosomes can be obtained from easily accessible bodily fluids, such as blood and urine, they offer a promising alternative to traditional biopsies, allowing for real-time monitoring of disease progression and treatment response. This potential for liquid biopsy applications is encouraging pharmaceutical companies and research institutions to invest in exosome research products, hoping to develop efficient, non-invasive diagnostic tests that improve early disease detection.

The pharmaceutical industry is also exploring the use of exosomes as drug delivery vehicles due to their natural biocompatibility and ability to cross biological barriers, such as the blood-brain barrier. This property makes exosomes particularly valuable for delivering drugs to hard-to-reach areas, such as the brain, in treating neurological diseases. Additionally, exosome-based therapies are gaining attention in regenerative medicine, where they are used to promote tissue repair and wound healing by delivering growth factors to target cells. Vaccine development is yet another emerging area, with exosomes being tested as carriers for antigens in immune response modulation. These expanding applications across multiple medical fields highlight the growing demand for specialized exosome research products that support the isolation, modification, and functional analysis of exosomes for therapeutic and diagnostic purposes.

What’s Driving the Growth of the Global Exosome Research Products Market?

The growth in the exosome research products market is driven by several factors, rooted in technological innovation, the expanding scope of exosome applications, and increasing investment in biomedical research. Technological advancements in exosome isolation and characterization tools have significantly improved the precision and efficiency of exosome research, enabling their use in highly sensitive applications such as biomarker discovery and therapeutic delivery. As diagnostic and therapeutic applications for exosomes continue to expand, pharmaceutical and biotech companies are heavily investing in the development of exosome-based products, particularly for cancer diagnostics, neurodegenerative diseases, and regenerative therapies. These factors are propelling demand for high-quality research products that facilitate the isolation, analysis, and modification of exosomes. Additionally, the rise of personalized medicine and the demand for non-invasive diagnostic tools are major drivers of market growth, as exosomes offer a minimally invasive option for disease monitoring and drug delivery. Increased funding from both public and private sectors is also accelerating the market, as institutions recognize the potential of exosome research in addressing unmet medical needs. The development of exosome-based therapeutics and the growing interest in leveraging exosomes for vaccine delivery further contribute to the demand for specialized research products. Collectively, these factors are positioning exosome research as a critical field within life sciences, supporting sustained growth in the market for exosome isolation kits, characterization tools, and analytical technologies.

SCOPE OF STUDY:

The report analyzes the Exosome Research Products market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Kits & Reagents, Instruments, Services); Application (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Other Applications); End-Use (Academic & Research Institutes, Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • AMS Biotechnology Ltd.
  • Bio-Techne
  • Lonza Group AG
  • Miltenyi Biotech
  • Nanosomix
  • Norgen Biotek Corp.
  • NX Pharmagen
  • Qiagen N.V.
  • System Biosciences (SBI)
  • Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Exosome Research Products - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Interest in Exosome-Based Diagnostics and Therapeutics Drives Growth in Exosome Research Products and Technologies
    • Increased Focus on Cancer Research Expands Demand for Exosome Products as Biomarkers for Early Detection and Monitoring
    • Advances in Exosome Isolation and Purification Technologies Improve Accuracy, Supporting Growth in Research Applications
    • Growing Investment in Regenerative Medicine Fuels Demand for Exosome Products in Cell Therapy and Tissue Engineering
    • Expansion of Precision Medicine Drives Demand for Exosome Products in Personalized Drug Delivery Solutions
    • Increased Adoption of Exosome-Based Liquid Biopsies Expands Applications in Non-Invasive Cancer Screening
    • Technological Advancements in Exosome Characterization Tools Enhance Research Capabilities for Drug Development
    • Rising Demand for Exosome Products in Neurological Disorders Supports Research in Brain and CNS Therapeutics
    • Growing Interest in Exosome-Based Vaccine Development Fuels Demand for High-Quality Exosome Research Products
    • Increasing Research Funding for Extracellular Vesicle (EV) Studies Drives Demand for Exosome Isolation Kits and Reagents
    • Expansion of Exosome Research in Cardiovascular and Autoimmune Diseases Supports Development of Targeted Therapies
    • Advances in Microfluidic and Nanotechnology-Based Exosome Isolation Methods Enhance Precision and Efficiency
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Exosome Research Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Exosome Research Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 10: World 6-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals & Clinical Testing Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World 6-Year Perspective for Hospitals & Clinical Testing Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 14: World 6-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Lung Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 16: World 6-Year Perspective for Lung Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World 6-Year Perspective for Breast Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 20: World 6-Year Perspective for Prostate Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 21: World Recent Past, Current & Future Analysis for Colorectal Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 22: World 6-Year Perspective for Colorectal Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 25: World Exosome Research Products Market Analysis of Annual Sales in US$ for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
  • JAPAN
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
  • CHINA
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
  • EUROPE
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Exosome Research Products by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Exosome Research Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
  • FRANCE
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 58: France Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
  • GERMANY
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
  • ITALY
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
  • UNITED KINGDOM
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 76: UK Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of World 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030

IV. COMPETITION